United States · Bill · HR
H.R. 6620 (116th)
To authorize grants to address substance use during COVID-19.
Introduced
24 April 2020
Last action
—
Status
Referred to the House Committee on Energy and Commerce.
Sponsors
—
Subjects
Discovery layer
Source updated
3 January 2025
Summary
This bill requires the Substance Abuse and Mental Health Services Administration (SAMHSA) to award grants to eligible jurisdictions and community-based organizations to address the harms of substance misuse, including by encouraging actions to reduce health impacts of substance use during national disasters and emergencies. SAMHSA shall prioritize grants by accounting for such factors as drug overdose death rates.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 24 April 2020
Introduced in House (PDF)
Introduced in House · EN · 24 April 2020
Introduced in House
summary · EN · 24 April 2020
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/house-bill/6620
- Open data entity: https://api.congress.gov/v3/bill/116/hr/6620